Spero Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $532.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-12
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $2.97M.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$2.44M.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$2.23M, a 193.11% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.08M, a 79.65% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$12.15M, a 208.77% decline from fiscal 2024.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $11.17M.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$2.42M.
- Spero Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$5.38M, a 354.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $532.00K 10-Q · filed 2026-08-12 | -$1.70M derived: sum of 3 quarters · filed 2026-08-12 | -$617.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$2.44M 10-Q · filed 2026-05-13 | -$4.67M derived: sum of 2 quarters · filed 2026-05-13 | -$3.58M derived: sum of 3 quarters · filed 2026-05-13 | -$5.05M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.15M derived: sum of 2 quarters · filed 2026-03-26 | -$2.61M derived: sum of 3 quarters · filed 2026-08-12 | -$12.15M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$379.00K derived: sum of 2 quarters · filed 2026-08-12 | -$9.91M 10-Q · filed 2025-11-13 | -$7.52M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$11.00M 10-Q · filed 2026-08-12 | -$8.60M derived: sum of 3 quarters · filed 2026-08-12 | -$3.28M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$9.54M 10-Q · filed 2026-05-13 | -$7.14M derived: sum of 2 quarters · filed 2026-05-13 | -$1.82M derived: sum of 3 quarters · filed 2026-05-13 | $2.81M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $7.71M derived: sum of 2 quarters · filed 2026-03-26 | $12.34M derived: sum of 3 quarters · filed 2026-03-26 | $11.17M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $5.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.95M derived: sum of 2 quarters · filed 2025-11-13 | $8.77M 10-Q · filed 2025-11-13 | $8.77M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $3.45M 10-Q · filed 2025-08-12 | $3.45M derived: sum of 3 quarters · filed 2025-08-12 | $4.41M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$1.18M 10-Q · filed 2025-05-13 | -$1.18M derived: sum of 2 quarters · filed 2025-05-13 | -$221.00K derived: sum of 3 quarters · filed 2025-05-13 | -$3.48M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $956.00K derived: sum of 2 quarters · filed 2025-03-27 | -$2.31M derived: sum of 3 quarters · filed 2025-03-27 | -$2.42M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $962.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.30M derived: sum of 2 quarters · filed 2024-11-14 | -$2.41M 10-Q · filed 2024-11-14 | -$1.53M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$3.37M 10-Q · filed 2024-08-05 | -$2.49M derived: sum of 3 quarters · filed 2024-08-05 | -$2.91M derived: sum of 4 quarters · filed 2024-08-05 | ||||
| 2023-03-31 | -$111.00K 10-Q · filed 2024-05-15 | $769.00K derived: sum of 2 quarters · filed 2024-05-15 | $351.00K derived: sum of 3 quarters · filed 2024-05-15 | -$198.00K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $880.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $462.00K derived: sum of 2 quarters · filed 2024-03-13 | -$87.00K derived: sum of 3 quarters · filed 2024-03-13 | -$5.38M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$967.00K derived: sum of 2 quarters · filed 2023-11-13 | -$6.26M 10-Q · filed 2023-11-13 | -$963.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$549.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$5.84M 10-Q · filed 2023-08-10 | -$545.00K derived: sum of 3 quarters · filed 2023-08-10 | -$416.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$5.29M 10-Q · filed 2023-05-11 | $4.00K derived: sum of 2 quarters · filed 2023-05-11 | $133.00K derived: sum of 3 quarters · filed 2023-05-11 | -$3.81M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.42M derived: sum of 2 quarters · filed 2023-03-30 | $1.49M derived: sum of 3 quarters · filed 2023-03-30 | $2.11M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.81M derived: sum of 2 quarters · filed 2022-11-14 | -$3.19M 10-Q · filed 2022-11-14 | -$4.11M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$3.31M 10-Q · filed 2022-08-10 | -$4.24M derived: sum of 3 quarters · filed 2022-08-10 | -$7.59M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $624.00K 10-Q · filed 2022-05-16 | -$302.00K derived: sum of 2 quarters · filed 2022-05-16 | -$3.65M derived: sum of 3 quarters · filed 2022-05-16 | $781.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$4.27M derived: sum of 2 quarters · filed 2022-03-31 | $157.00K derived: sum of 3 quarters · filed 2022-03-31 | -$9.13M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.08M derived: sum of 2 quarters · filed 2021-11-10 | -$8.20M 10-Q · filed 2021-11-10 | -$8.35M 10-Q · filed 2020-11-05 | $2.32M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.86M 10-Q · filed 2021-08-05 | -$4.84M 10-Q · filed 2020-08-06 | $5.67M derived: sum of 3 quarters · filed 2021-08-05 | $10.81M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | -$9.29M 10-Q · filed 2021-05-06 | -$9.38M 10-Q · filed 2020-05-08 | $1.24M derived: sum of 2 quarters · filed 2021-05-06 | $6.38M derived: sum of 3 quarters · filed 2021-05-06 | $7.35M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $15.67M derived: sum of 2 quarters · filed 2021-03-11 | $16.64M derived: sum of 3 quarters · filed 2021-03-11 | $13.27M 10-K · filed 2021-03-11 | $13.61M 10-K · filed 2020-03-16 | |||
| 2019-09-30 | $5.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.11M derived: sum of 2 quarters · filed 2020-11-05 | $2.75M 10-Q · filed 2020-11-05 | $3.95M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $966.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.40M 10-Q · filed 2020-08-06 | -$1.20M derived: sum of 3 quarters · filed 2020-08-06 | $367.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$3.36M 10-Q · filed 2020-05-08 | -$2.16M derived: sum of 2 quarters · filed 2020-05-08 | -$599.00K derived: sum of 3 quarters · filed 2020-05-08 | $46.00K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.77M derived: sum of 2 quarters · filed 2020-03-16 | $3.41M derived: sum of 3 quarters · filed 2020-03-16 | $3.58M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $2.21M derived: sum of 2 quarters · filed 2019-11-04 | $2.37M 10-Q · filed 2019-11-04 | $2.68M derived: sum of 4 quarters · filed 2019-11-04 | ||||
| 2018-06-30 | $645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $810.00K 10-Q · filed 2019-08-08 | $1.11M derived: sum of 3 quarters · filed 2019-08-08 | $366.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $165.00K 10-Q · filed 2019-05-09 | $469.00K derived: sum of 2 quarters · filed 2019-05-09 | -$279.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.05M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$444.00K derived: sum of 2 quarters · filed 2019-03-14 | $881.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.31M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | -$748.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $577.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.01M 10-Q · filed 2018-11-08 | $1.11M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.76M 10-Q · filed 2018-08-09 | $1.85M derived: sum of 3 quarters · filed 2019-03-14 | |||||
| 2017-03-31 | $434.00K 10-Q · filed 2018-05-10 | $530.00K derived: sum of 2 quarters · filed 2019-03-14 | ||||||
| 2016-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.32M 10-K · filed 2019-03-14 | ||||||
| 2016-09-30 | $2.23M 10-Q · filed 2017-12-14 | |||||||
| 2015-12-31 | $409.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |